Skip to content
Clinical Trials – home

Dexchlorpheniramine Maleate: A Comprehensive Guide for Patients

4 / 5
trials open to patients / all trials
12+
Countries

In short

Dexchlorpheniramine Maleate, a topical antihistamine, has been the subject of several clinical trials investigating its effectiveness in treating various skin conditions. These studies have focused on comparing different formulations of the drug, such as creams, gels, and lotions, for relieving symptoms associated with insect bites and sunburn. The trials aim to evaluate the efficacy and safety of these formulations in providing relief from itching, redness, and other related symptoms.

At a glance

Drug Formulations
1% Cream, 1% Gel, 1% Lotion
Conditions Studied
Insect Bites, Sunburn
Application Method
Small amount applied over the lesion twice a day for 7 days
Primary Outcome Measure
Pruritus intensity using 10-point Visual Analog Scale (VAS)
Secondary Outcome Measure
Composite clinical evaluation of symptoms (4-point scale)
Study Design
Non-inferiority, comparative open studies
Study Locations
Brazil (approved by ANVISA)

What is Dexchlorpheniramine Maleate?

Dexchlorpheniramine Maleate is an antihistamine medication. Antihistamines are drugs that help reduce or block the effects of histamine, a substance your body produces during allergic reactions. This medication is used to treat various allergic conditions and provide relief from associated symptoms.

Uses of Dexchlorpheniramine Maleate

Dexchlorpheniramine Maleate is used to treat several conditions, including:

  • Insect bites: It helps relieve symptoms such as itching (pruritus) and swelling (papules) caused by insect bites.
  • Sunburn: The medication can alleviate sunburn-related symptoms like redness (erythema), itching, and burning sensations.
  • Skin irritations and allergies: It's effective in treating various skin irritations and allergic reactions.
  • Upper respiratory tract infections: In combination with other medications, it can help relieve allergic symptoms in patients with viral upper respiratory tract infections.

Available Formulations

Dexchlorpheniramine Maleate is available in several formulations for topical (on the skin) and oral use:

  • Cream: A 1% cream formulation for application on the skin.
  • Gel: A 1% gel formulation, also for topical use.
  • Lotion: A 1% lotion formulation for skin application.
  • Oral solution: A liquid form for oral consumption, often combined with other medications.

How Dexchlorpheniramine Maleate Works

Dexchlorpheniramine Maleate works by blocking the effects of histamine in your body. Histamine is a substance released by your immune system during allergic reactions. When you have an allergic reaction, such as to an insect bite or sunburn, your body releases histamine, which causes symptoms like itching, swelling, and redness. By blocking histamine, Dexchlorpheniramine Maleate helps reduce these symptoms.

Effectiveness in Clinical Trials

Several clinical trials have been conducted to evaluate the effectiveness of Dexchlorpheniramine Maleate:

  • For insect bites: Studies have compared different formulations (cream, gel, and lotion) to assess their effectiveness in relieving insect bite symptoms. The primary measure was the reduction in itching intensity, evaluated using a 10-point Visual Analog Scale (VAS).
  • For sunburn: Clinical trials have evaluated the efficacy of Dexchlorpheniramine Maleate in relieving sunburn-related symptoms. These studies also used the VAS to measure the reduction in itching intensity.
  • For respiratory infections: A study compared Dexchlorpheniramine alone to a combination of Dexchlorpheniramine, pseudoephedrine, and guaifenesin in relieving allergic symptoms in patients with viral upper respiratory tract infections.

How to Use Dexchlorpheniramine Maleate

The administration of Dexchlorpheniramine Maleate depends on its formulation:

  • Topical formulations (cream, gel, lotion): Apply a small amount over the affected area twice a day for 7 days.
  • Oral solution: Typically, 5 mL (containing 2 mg of Dexchlorpheniramine) is taken four times a day for 5 days.

Always follow your healthcare provider's instructions or the directions on the product label.

Combination Treatments

Dexchlorpheniramine Maleate is sometimes used in combination with other medications for enhanced effectiveness:

  • Dexchlorpheniramine + Pseudoephedrine + Guaifenesin: This combination is used for treating allergic symptoms in patients with viral upper respiratory tract infections and productive cough. Pseudoephedrine acts as a decongestant, while guaifenesin is an expectorant that helps loosen mucus.

Safety and Side Effects

While Dexchlorpheniramine Maleate is generally considered safe when used as directed, it's important to be aware of potential side effects. The clinical trials mentioned in this article also aimed to evaluate the safety of different formulations.

Common side effects of antihistamines like Dexchlorpheniramine Maleate may include drowsiness, dry mouth, and dizziness. When used topically, there might be local skin reactions. Always consult with your healthcare provider about potential side effects and how to manage them.

Questions people often ask

Conditions where Dexchlorpheniramine Maleate is being studied

Each condition opens its own overview and trial list

Trials with Dexchlorpheniramine Maleate

Recruiting trials first

See all 5 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).